Drugs / inhaled nitric oxide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT00543933 | Oct 2007 → Jun 2010 | pulmonary valve insufficiency | The Cleveland Clinic | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | inhaled nitric oxide | “This study assessed whether pulmonary regurgitant fraction measured by cardiovascular magnetic resonance (CMR) could be reduced with inhaled nitric oxide (iNO).” PMID 24006858 ↗ Sep 2013 |
| Known as | iNO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00543933 ↗ |
| Route | Inhaled | “Inhaled nitric oxide in patients with pulmonic valve insufficiency.” NCT00543933 ↗ |